Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.77 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | TSHR | P16473 | 3/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | SHBG | P04278 | 1/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 3/20 | 0.56 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | CA7 | P43166 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31166012 | 1.00 | HTT (0.77) | HTTHSP90AB1ALDH1A1TSHRHSD17B10 | |
| SCHEMBL3659979 | 0.89 | HTT (0.90) | HTTHSP90AB1ALDH1A1TSHRHSD17B10 | |
| SCHEMBL6427459 | 0.88 | HSP90AB1 (0.70) | HTTHSP90AB1ALDH1A1TSHRHSD17B10 | |
| SCHEMBL1606859 | 0.87 | HTT (1.00) | HTTHSP90AB1ALDH1A1HPGDKDM4E | |
| SCHEMBL3660585 | 0.86 | HTT (0.97) | HTTHSP90AB1ALDH1A1TSHRHPGD | |
| SCHEMBL3662077 | 0.86 | HTT (0.97) | HTTHSP90AB1ALDH1A1TSHRHPGD | |
| SCHEMBL3659193 | 0.86 | HTT (0.97) | HTTHSP90AB1ALDH1A1TSHRHPGD | |
| Water SCHEMBL5859867 | 0.86 | HTT (0.97) | HTTHSP90AB1ALDH1A1TSHRHSD17B10 | |
| SCHEMBL3656872 | 0.86 | HTT (0.97) | HTTHSP90AB1ALDH1A1TSHRHPGD | |
| SCHEMBL3659335 | 0.86 | HTT (0.97) | HTTHSP90AB1ALDH1A1TSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025092541-A1 | LITHIUM EXTRACTION RESIN STRUCTURE, PREPARATION, AND USE | 北京索特莱克科技发展有限公司 | 2025-05-08 | — | — | WO | claimed |
| CN-114031483-B | Synthesis method of 4-butylresorcinol | 河南旭瑞新材料科技有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-110511117-B | Method for synthesizing 4-n-butylresorcinol by microchannel reaction | 上海昕凯医药科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114031483-A | Novel synthesis method of 4-butyl resorcinol | 河南旭瑞新材料科技有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-109534961-B | Method for synthesizing 4-alkylresorcinol by solvent-free system | 上海贤鼎生物科技有限公司 | 2020-10-02 | — | — | CN | claimed |
| US-5080997-A | PROCESS FOR PREPARING A POSITIVE RESIST COMPOSITION BY MIXING THE CONDENSATION PRODUCT OF A QUINONE DIAZIDE SULFONYL HALOGENIDE AND A PHENOL WITH A RESIN SOLUTION WITHOUT ISOLATING THE CONDENSATION PRODUCT FROM THE CRUDE MIXTURE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-01-14 | — | — | US | claimed |
| EP-4126835-B1 | INHIBITORS OF ANTIGEN PRESENTATION BY HLA-DR | JANSSEN PHARMACEUTICA NV (BE) | 2026-02-18 | — | — | EP | disclosed |
| US-12516038-B2 | Inhibitors of antigen presentation by HLA-DR | JANSSEN PHARMACEUTICA NV (BE) | 2026-01-06 | — | — | US | disclosed |
| CN-120025229-A | Method for preparing 4-n-butyl resorcinol | 山东君泰药业有限公司 | 2025-05-23 | — | — | CN | disclosed |
| WO-2025092541-A1 | LITHIUM EXTRACTION RESIN STRUCTURE, PREPARATION, AND USE | 北京索特莱克科技发展有限公司 | 2025-05-08 | — | — | WO | disclosed |
| US-20250084049-A1 | POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF | FIRMENICH INCORPORATED (US) | 2025-03-13 | — | — | US | disclosed |
| CN-114031483-B | Synthesis method of 4-butylresorcinol | 河南旭瑞新材料科技有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-114031483-B | Synthesis method of 4-butylresorcinol | 河南旭瑞新材料科技有限公司 | 2024-10-11 | — | — | CN | disclosed |
| EP-0061015-B1 | PROCESS FOR THE PREPARATION OF A 2-ALKYLPHENOL | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1984-04-11 | — | — | EP | disclosed |
| EP-0037563-B1 | SULFUR DYES OF THE CARBAZOLE SERIES, THEIR PREPARATION AND APPLICATION, AS WELL AS INTERMEDIATE COMPOUNDS | CASSELLA Aktiengesellschaft (DE) | 1984-02-15 | — | — | EP | disclosed |
| US-4419529-A | Process for the preparation of a 2-alkylphenol | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1983-12-06 | — | — | US | disclosed |
| US-4360459-A | Sulphur dyestuffs of the carbazole series | CASSELLA AKTIENGESELLSCHAFT (DE) | 1982-11-23 | — | — | US | disclosed |
| EP-0061015-A1 | Process for the preparation of a 2-alkylphenol | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1982-09-29 | — | — | EP | disclosed |
| EP-0037563-A1 | Sulfur dyes of the carbazole series, their preparation and application, as well as intermediate compounds | CASSELLA Aktiengesellschaft (DE) | 1981-10-14 | — | — | EP | disclosed |
| US-3933737-A | SULFUR-CONTAINING ORGANOTIN COMPOUNDS AND NON-SULFUR-CONTAINING ORGANOTIN COMPOUNDS | KABEL-UND METALLWERKE GUTEHOFFNUNGSHUTTE AKTIENGESELLSCHAFT (DT) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084049-A1 | POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF | PGC, SLC5A6, PUF60 | HTT 531/4885HSP90AB1 2202/4885ALDH1A1 2754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.